Effects of Yangxinshi Pills on the Exercise Tolerance Compared With Trimetazidine in Patients After PCI (HEARTRIP)
Effects of Yangxinshi Pills on the Exercise Tolerance Compared With Trimetazidine in Patients After PCI: a Prospective，Muhicenter,Doubleblind, Double-dummy, Randomized, Controlled Trial
Sponsor: Shenyang Northern Hospital
Listed as NCT03809273, this PHASE4 trial focuses on Percutaneous Coronary Intervention and remains completed. Sponsored by Shenyang Northern Hospital, it has been updated 9 times since 2019, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
9 versions recorded-
Oct 2025 — Present [monthly]
Completed PHASE4
Status: Unknown → Completed
-
Sep 2024 — Oct 2025 [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Nov 2022 — Jul 2024 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jan 2021 — Nov 2022 [monthly]
Recruiting PHASE4
▶ Show 4 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
Oct 2019 — Nov 2020 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Jul 2019 — Oct 2019 [monthly]
Not Yet Recruiting PHASE4
-
Feb 2019 — Jul 2019 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Shenyang Northern Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Beijing, China , Cangzhou, China , Changchun, China , Chongqing, China , Dalian, China , Guangzhou, China , Hefei, China , Jinan, China , Qingdao, China , Shanghai, China and 3 more locations